The eye of Ai er swallow Tianjin meg

Ai Seoul Eye Notice yesterday, to 38.8 million yuan to acquire and increase the capital Tianjin Macquarie Ophthalmic Hospital Limited liability company (Tianjin Macquarie). This is following its previous acquisition of Wheat eye Nanchong, Chongqing, Shijiazhuang, 3 clinics after another masterpiece.　　Yesterday, Ai Seoul closed 42.75 yuan, down 2.62%. AI Seoul to use more than 38.8 million yuan to raise funds to acquire equity and increase capital expansion of the way to invest in Tianjin Macquarie. The company calculates that the static investment payback period of this project is 4.96 years, and the investment profit margin of the project is 19.6%.　　The company said the project will help speed up the medical network layout in Tianjin, and further enhance the company's market coverage and industry position throughout the country. Ai er eye IPO when the super raise money up to 540 million yuan, in the main business has spent 110 million yuan, still save 430 million yuan. Chairman Chen Bong said that the money will be based on company planning for the main business, is expected to be completed within two years. Chen Bong also said that if there is a good mark, the acquisition, the acquisition is not, the new.　　Now, the momentum for its expansion through acquisitions is significantly stronger. Many brokers believe that most of the company's former provincial capitals were built by themselves, the break-even point is basically in 1-2 years, and the existing ophthalmic hospital, because already have a certain basis, it can shorten the time to achieve break-even point, but also help the company to acquire talent, reduce competitors.　　Company Dong Han Zhong also said that the acquisition will become an important complement to the expansion strategy, peer hospital has a mature human and licensing resources, will make the profit period greatly shortened. Brokers expect that, after the completion of the provincial capital city, the "three-level chain" mode will be truly on the stage.　　The so-called "three-level chain" mode, is the company according to ophthalmic medical characteristics, will be the most clinical and scientific research ability of Shanghai love you four or five medical center as a first-level hospital, the provincial capital city as a stronghold to expand the two-level hospital, in-depth municipal cities to establish a three-level hospital, to strengthen This model is for some institutional investors, some call it another "Suning appliance", the last four quarters of the private equity fund to intervene in the stock, the first quarter of this year, there are two public offering funds to buy. This year, the market oscillation fell more than 20%, but the shares after the right to recovery still more than 75%.